BLUE – Bluebird Bio Inc is focused on developing and commercializing drugs based on gene therapy to treat patients with genetic diseases and cancer.

BLUE – Bluebird Bio Inc

Fundamentals Previously closed at 47.72
Day’s high 51.46
Day’s low 47.61
P/E ratio NA
EPS -2.44


Analysts opinion Bluebird Bio announced that its ongoing phase 2 study evaluating the product candidate “Lenti-D” for the treatment of cerebral adrenoleukodystrophy (CALD) will be presented today at the American Academy of Neurology (AAN) Annual Meeting. The news for the investigational drug Lenti- D seems to be positive, with all patients remaining free of MFDs, and consistent safety-profile. The revenues for the stock is expected to be reported on May 4th, and analysts estimate EPS at $-1.19. Technically, bluebird has formed a double-bottom chart pattern, and is expected to be bullish.
Sentiments Also, Deutsche Bank AG and Bank of America Corp DE have boosted their stakes in BLUE and investor sentiment seems to be bullish.
Social Media Pulse The stock has 100% higher chatter than usual.


VMW– VMWare Inc provides virtualized infrastructure solutions in the categories of software defined data center, hybrid cloud computing, and End User Computing.

VMW – VMWare Inc

Fundamentals Previously closed at 51.46
Day’s high 52.17
Day’s low 51.13
P/E ratio 25.57
EPS 2.27


Analyst opinion VMWare reported its first quarter EPS of $0.86, beating the wall street forecast of $0.84 – helped by strong sales of its new virtualization software. VMWare had been trading lower since the announcement of Dell-EMC (parent company) merger last year due to fears the merger may harm VMWare’s data centre business. Today, VMWare announced that it would begin a $1.2 billion stock buyback after EMC shareholder’s vote on Dell acquisition. This buyback would boost EMC’s value in two ways – it would increase EMC’s and VMWare’s share prices, and also increase its market value post Dell acquisition, since the basis of the tracking stock being offered for the acquisition of Dell is valued at 0.111xVMWare stock price.
Sentiments Due to the positive revenues and the news of $1.2 Billion buyback, investors are bullish for the stock.
Social Media Pulse The stock has 100% higher social chatter than usual.



Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See

Leave a Reply

Your email address will not be published. Required fields are marked *